PD-2 Activators are a selective group of chemical compounds that enhance the functional activity of PD-2 through modulation ofspecific signaling pathways and cellular processes. Forskolin and 8-Bromo-cAMP, by increasing intracellular cAMP levels, indirectly enhance PD-2's functional activity via PKA activation, which may phosphorylate PD-2 or modulate processes in which PD-2 is involved. Similarly, Dibutyryl cAMP acts as a stable cAMP analog, targeting the same PKA-dependent pathways to potentially enhance PD-2 activity. Sildenafil, by inhibiting PDE5, increases cGMP levels, thereby activating PKG pathways that could intersect with PD-2's regulatory mechanisms. Phorbol 12-myristate 13-acetate (PMA) activates Protein Kinase C (PKC), and if PD-2 is a substrate or modulated by PKC, PMA would enhance its activity. Ionomycin, through increased intracellular calcium, could activate calcium-dependent pathways that regulate PD-2, while Epigallocatechin gallate (EGCG) may lift inhibitory kinase regulation on PD-2, thereby enhancing its activity.
Further indirect modulation of PD-2 activity is achieved through compounds that influence the MAPK and PI3K/Akt pathways. LY294002, a PI3K inhibitor, could shift cellular signaling to favor PD-2's function if PD-2 is associated with the PI3K/Akt pathway. SB203580 and U0126, which inhibit p38 MAPK and MEK1/2 respectively, could redirect signaling to enhance PD-2 activity if PD-2 is involved in signaling cascades usually restrained by these kinases. AICAR, an AMPK activator, suggests potential enhancement of PD-2 function through AMPK-regulated pathways. ZM-447439's role as an Aurora kinase inhibitor implies that if PD-2's activity is suppressed by Aurora kinases, its inhibition would lead to an enhancement of PD-2's function. Collectively, these compounds, through their targeted effects on distinct signaling pathways, offer a comprehensive approach to enhancing the functional activity of PD-2 without necessitating changes in gene expression or direct activation of the protein.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA functions as a diacylglycerol analog, activating protein kinase C (PKC). If PD-2 is a substrate of PKC or is regulated by PKC-mediated signaling, PMA would enhance PD-2's functional activity through the PKC pathway. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing intracellular cAMP levels. Elevated cAMP activates PKA, which may then phosphorylate PD-2 or modulate its activity if PD-2 is part of a cAMP-dependent pathway. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. If PD-2's function is calcium-dependent, ionomycin would indirectly enhance PD-2 activity by raising intracellular calcium concentrations. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol that can inhibit certain protein kinases. If PD-2's activity is negatively regulated by a kinase that EGCG inhibits, then EGCG may enhance PD-2 activity by lifting this inhibition. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a cell-permeable cAMP analog. It activates PKA, and if PD-2 is regulated by PKA-mediated phosphorylation, 8-Bromo-cAMP could enhance PD-2 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. If PD-2 operates downstream of PI3K or within PI3K-regulated pathways, inhibiting PI3K could shift cellular signaling in favor of enhancing PD-2's activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. If PD-2 is part of a signaling cascade that is normally inhibited by p38 MAPK, then inhibition of this kinase could result in the enhancement of PD-2 activity. | ||||||
AICAR | 2627-69-2 | sc-200659 sc-200659A sc-200659B | 50 mg 250 mg 1 g | $65.00 $280.00 $400.00 | 48 | |
AICAR activates AMPK, and if PD-2 activity is enhanced by AMPK signaling or if PD-2 interacts with pathways controlled by AMPK, AICAR could indirectly enhance PD-2's functional activity. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
ZM-447439 is an Aurora kinase inhibitor. If PD-2's activity is suppressed by Aurora kinases, its inhibition could lead to the enhancement of PD-2's function. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl cAMP is a stable cAMP analog that activates PKA. If PD-2 is regulated through PKA-dependent phosphorylation, this compound could enhance PD-2's activity. | ||||||